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We obtained eight different cell lines in the long-term bone marrow culture system that
showed a germ-line configuration of the joining (J) region segments of the Ig heavy-chain
(IgH) genes. Their surface markers were CD45R 4, Ly-l/, Lyb-2 +, cIgM-, slgM-, Ia-, Thy-l-,
Mac-l-, and IL-2R (Tac)4. Use of very young mice and the presence of IL-5 were important
for preferential promotion of the survival of B-lineage lymphocytes bearing the Ly-1
markers. When we treated two of them (J8 and J10) with 5-azacytidine for 24 h followed by
co-culture with stromal cells and IL-.5, they became Ly-14, sIgM
4 B cells, and Ly-14, Mac-14
macrophagelike cells, respectively. After other early lymphoid lines (J1, J8, and J13) were
maintained by co-culture with ST2 and IL-5 for more than a year, they showed a hetero-
geneous DNA rearrangement profile of the J region segment of the IgH gene, although only
J13 rearranged the c-light chain gene. Northern blot analysis revealed that these cell lines
expressed C/z-mRNA, and 25-mRNA, consistent with normal pre-B cells. Intriguingly, J1, J8,
and J13 expressed c-fins mRNA constitutively. When J13 cells were co-cultured with ST2 and
GM-CSF in place of ST2 and IL-5, they acquired Mac-1 expression and retained Ly-1
expression. They were morphologically macrophages, nonspecific-esterase-positive, and
showed phagocytosis of latex beads. These results support evidence for a close relationship
between the myeloid and Ly-1
/ B-cell pathways of differentiation, and indicate that our IL-
5-dependent clones are multipotential intermediates in differentiation from pro-B cells to B
cells and macrophages.
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INTRODUCTION
B lymphocytes derive from hematopoietic stem cells
in bone marrow that also generates myeloid and
erythroid elements, but decisive commitment to the
lymphoid lineage is championed by deletions that
create a functional immunuglobulin (Ig) heavy-chain
variable gene (Kincade, 1987). These deletions occur
at a defined stage of lymphoid ontogeny and are
characteristic of each lymphocyte clone. Intriguingly,
from several tumors bearing a B-lineage marker, it
has been possible to obtain cells with myeloid
characteristics, such as macrophages (Boyd and
Schrader, 1982; Bauer et al., 1986; Holmes et al.,
1986). Conversely, Ig gene rearrangements have
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recently been detected in a subset of acute mye-
logenous leukemias (Seremitis et al., 1987). Further-
more, cloned pre-B- and B-cell lines from bone
marrow cells in E/,t-myc transgenic mice infected
with a retrovirus bearing v-raf changed into either
mature or immature macrophages, but retained
clonotypic Ig gene rearrangements (Klinken et al.,
1988). One interpretation of such observations is
that the B and myeloid lineages are unexpectedly
close (Holmes et al., 1986; Davidson et al., 1988).
IL-5 has been defined as a growth and differentia-
tion factor acting on mature murine B cells (Kinashi
et al., 1986; Coffman et al., 1988; Takatsu et al.,
1988). Studies on functional properties of rIL-5
revealed that IL-5 acts at least on B cells, T cells,
and eosinophils, inducing their growth and differen-
tiation (Takatsu et al., 1987; Yokota et al., 1987;
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Sanderson et al., 1988; Coffman et al., 1989). We
also reported that IL-5 is at least one growth factor
that can sustain growth of Ly-1 positive B-lineage
cell lines (Tominaga et al., 1989). However, the role
of IL-5 in proliferation and differentiation of pro-
genitor cells for macrophages is still not clear.
We have now extended our previous studies and
established eight different IL-5-dependent Ly-1
/ and
CD45R
/ cell lines whose IgH gene configurations are
germ-line, and determined their potentials for dif-
ferentiation into B cells or macrophages. Both Ly-1
/
early B-lineage cells and Ly-1
/ pre-B cells differen-
tiated into not only Ly-1 B cells, but also Ly-1
/
macrophages when co-cultured with bone marrow
stromal cells and IL-5 and/or GM-CSF. The results
support earlier evidence for a close relationship
between the myeloid and certain B-cell pathways of
differentiation. They also inlicate that such IL-5-
dependent clones are useful tools for studying
mechanisms of differentiation of multipotential
progenitor cells into B cells and macrophages.
RESULTS
Derivation and Characterization of IL-5- and
Stromal-Cell-DependentCell Lines
We first compared the appearance of Ly-1
/
B-lineage cells in the original Whitlock-Witte type
long-term bone marrow culture (LTBC-W) (Whitlock
and Witte, 1982) of 3-week-old bone marrow cells or
8-week-old bone marrow cells of DBA/2J mice. After
4 weeks, we characterized the appearance of Ly-1
and CD45R antigens. As shown in Fig. 2A, cell
growth of a distinct Ly-1
/ and CD45R
/ B-lineage
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FIGURE 1. Phenotypic characteristics of the Ly-1 clones. (A) Bone marrow cells of 3-week-old or 8-week-old DBA/2J mice were
cultured in LTBC-W for 4 weeks. (B) Bone marrow cells from DBA/2J (3-week-old) or IL-5 transgenic C3H/HeN (3-week-old) mice were
cultured in LTBC-W for 5 weeks. Nonadherent cells were then transferred onto the ST2 layer and cultured with or without IL-5 (50 U/
ml) for 5 weeks. Cells thus obtained were stained with FITC-conjugated anti-Ly-1 and anti-CD45R plus FITC-coupled anti-rat c and
were analyzed by a flow cytometry. In the case of (A), biotinylated anti-Ly-1 plus PE-avidin were used instead of FITC-conjugated
antibody. Negative controls were cells unstained or stained with the second-step reagent only.MACROPHAGE DIFFERENTIATION FROM PRE-B CELLS 115
cell population became evident in LTBC-W of
3-week-old bone marrow cells. In contrast, there
was very little Ly-1
/ population, if any, in LTBC-W
of 8-week-old bone marrow cells.
To evaluate the role of ST2 and IL-5 in the estab-
lishment of a Ly-1
/ B-lineage cell line, we cultured
bone marrow cells from 3-week-old DBA/2J mice or
from 3-week-old IL-5 transgenic (C3H/HeN) mice
whose bone marrow cells constitutively produce IL-5
(Tominaga et al., 1989). After 5 .weeks, nonadherent
cells of each culture were transferred onto the
stromal cell (ST2) layer (Ogawa et al., 1988) and
cultured in the presence or absence of IL-5 for
another 5 weeks. In DBA/2J bone rmarrow cells,
preferential induction of Ly-1
/ B-lineage cells was
observed only in the presence of IL-5 (Fig. 1B). In
contrast, Ly-1
/ B-lineage cells were induced in
LTBC-W of bone marrow cells from the IL-5 trans-
genic mice without adding exogenous IL-5.
Among 18 Ly-1
/ clones analyzed in this study,
eight clones showed the germ-line type IgH genes,
two clones had rearranged IgH genes in both
chromosomes, and eight clones displayed one re-
arranged IgH gene. All cell lines expressed CD45R
and Ly-1 antigens. In addition, they were cIgM-,
sIgM-, Mac-l-, Ia-, Thy-l-, and IL-2R(Tac)/. On the
basis of the foregoing phenotypic and molecular
criteria, these cell lines were equivalent to early
B-lineage progenitors. Five clones (J1, J2, J8, J10, and
J13) having a germ-line configuration of IgH genes
were selected and used for further analysis to
explore their differentiation potential.
Induction of Macrophages from B-lineage Cell Lines
We maintained five clones described in the previous
section on the ST2 layer with IL-5. Three months
later, all cell lines still showed a germ-line con-
figuration of IgH gene, except J8, which showed a
rearranged pattern of IgH genes. At this stage, we
did not note any change in cell-surface markers
from the parental clones (data not shown).
It has been reported that exposure of pre-B
lymphoma line to 5-azacytidine induced derivation
of macrophagelike lines (Boyd and Schrader, 1982).
We therefore cultured J8 and J10 cells in the
presence of various concentrations of 5-azacytidine.
Of cells cultured with 5/zg/ml 5-azacytidine, fed
after 24 h with fresh medium containing IL-5, and
co-cultured on the ST2 layer, only 10% of the initial
number were present after 7 days, and most of the
cells died within 2 weeks after the treatment. Some
of them started to grow after 3 weeks of treatment.
After 5 weeks, nonadherent cells (J8A and J10A)
were transferred into a flask with fresh ST2 layers
and maintained for 3 months in the presence of IL-
5. Southern blot analysis of the J8A DNA revealed
that the configuration of JH gene sequences was
rearranged, whereas J10A cells showed a germ-line-
type configuration like the parental cell line (J10)
(data not shown). A flow cytometry analysis
revealed that J8A cells were sIgM /, Ly-l/, and Mac-
1-, and J10A cells were sIgM-, Ly-1 /, and Mac-1
/
(Fig. 2). The J8A cells exhibited a characteristic
lymphocyte morphology. They were round, medium
to small in size, and had large nuclei with scanty
cytoplasm devoid of cytoplasmic granules. In
contrast, J10A cells were significantly larger, irregu-
larly shaped, and had a large pale cytoplasm riddled
with vacuoles-cytological features typical of macro-
phages (Fig. 3B) and distinctly different from
parental J10 ceils (Fig. 3A). T]aey were also non-
specific esterase-positive (Fig. 3D) and acquired the
ability to engulf latex particles (data not shown),
indicating that J10A cell8 have distinctive properties
of mature macrophages. J8A cells were nonspecific
esterase-negative (Fig. 3C). IL-5 was essential for
the conversion of pro-B cells (J8) to pre-B cells (J8A),
but itwas not essential for the conversion of pro-B
cells (J10) to macrophagelike cells (J10A) (data not
shown).
Establishment of Stromal Cell and IL-5-Depenclent
Pre-B Cells
Pre-B cell lines were also developed when the
original clones were maintained for more than a
year on the ST2 layer in the presence of IL-5. After
isolating J1, J8, and J13 cells on the ST2 monolayer
in the presence of IL-5, we continued the culture by
transferring nonadherent cells from flask to flask
with newly prepared ST2 monolayers every 3
weeks. During culture in the same flask, cells were
fed with fresh medium supplemented with IL-5
every 3 to 4 days. J1, J8, and J13 cells were CD45R /,
Ly-1 +, and Mac-l. Southern blot analysis revealed
that all cell lines thus obtained displayed rearranged
IgH gene configuration (Fig. 4A and 4B), and only
the J13 cell line showed J rearrangement (Fig. 4C).
To determine whether C/ transcripts were pro-
duced in early B-cell progenitors, Northern blots of
total RNA extracted from the panel of clones were
hybridized with a C/ probe. Two other pre-B cell
lines (70Z/3 and MJ88-1) and one mature B-cell line116 S. KATOH et al.
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FIGURE 2. Phenotype characteristics
of early B-lineage cell lines treated
with 5-azacytidine. The clones were
treated with 5-azacytidine as detailed
in Materials and Methods. Cells
obtained 5 weeks after completion of
the 5-azacytidine treatment were
stained with FITC-coupled anti-/z,
FITC-coupled anti-Ly-1, or anti-Mac-1
plus FITC-coupled anti-rat c and
analyzed by a flow cytometer. RELATIVE. FLUORESCENCE INTENSITY
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FIGURE 3. Morphological and cyto-
chemical analysis of the J10 clone and
its derivative J10A. Part (A) shows
cytocentrifuged J10 cells stained with
May-Gruenwald-Giemsa solution, and
(B) shows cytocentrifuged macro-
phage-converted J10A cells stained
with May-Gruenwald-Giemsa solu-
tion. Part (C) shows J8A cells stained
with nonspecific esterase, and (D)
shows J10A cells stained with
nonspecific esterase. The magnifica-
tion in each case was 400x. (See
Colorer Plate IV at the back of this
publication.)MACROPHAGE DIFFERENTIATION FROM PRE-B CELLS 117
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FIGURE 4. Southern blot analysis of pre-B cell lines. DNA of various cell lines were digested with (A) EcoRI, (B) XbaI, or (C) HindlII.
Digested DNA were analyzed by Southern blot using (A and B) JH4 probe or (C) Jk probe.
(BCL1-B20) were used as controls. MJ88-1 is an IL-5-
independent and ST2-dependent pre-B cell line
(Migita et al., in press). Expression of /J-actin was
also examined to normalize amounts of mRNA for
the analysis (Fig. 5D). As can be seen in Fig. 5A, J1,
J8, and J13 showed 2.7 kb mRNA corresponding to
membrane-type /z-chain, although the expression
was weaker than in 70Z/3 and MJ88-1 cells. Intri-
guingly, J1, J8, and J13 as well as 70Z/3 expressed
abundant mRNA for ,5 (Fig. 5B), whereas BCL1 did
not express 5 mRNA. The MJ88-1 cell line also
expressed abundant ,5 mRNA. To our surprise,
abundant c-fms mRNA was observed in all IL-5- and
ST2-dependent pre-B cell lines, whereas IL-5-
independent cell lines such as MJ88-1 and 70Z/3 did
not express c-fms mRNA (Fig. 5C). Small per-
centages (5-10%) of these cell lines expressed sIgM
(Fig. 6), but nbither surface c- nor A-light chain
expression was detectable. The lines were able to
grow only in the presence of 2-ME, and required
ST2 in addition to IL-5 for their growth.
Induction of Macrophages from Pre-B Cell Lines
We co-cultured the pre-B cell line J13 with ST2 plus
GM-CSF in place of ST2 plus IL-5, because c-fms
has been shown to encode receptors for M-CSF
(Sherr et al., 1985) and plays a role in monocyte
differentiation (Sariban et al., 1985). After 3 weeks
of culture, we found growth of Ly-1
/ cells (J13GM)
with macrophage morphology that had lost surface
/z-chain and acquired Mac-1 expression (Fig. 7).
Furthermore, they were nonspecific esterase-positive
(Fig. 8A) and could ingest latex beads (Fig. 8B). A
converted myeloid line (J13GM) had the same JH
rearrangement pattern as its lymphoid parent (J13)
(Fig. 4A). In the absence of ST2, it was difficult to
obtain macrophagelike cells and a conditioned
medium of ST2 could not replace the ST2 adherent
layer in this culture system. Multiple tests confirmed
that the lines were indeed myeloid and delineated
their stage of maturation. Converted cells had twice
the doubling time of the parental lines, an obser-118 S. KATOH et al.
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FIGURE 5. Expression of mRNA in
pre-B cell lines. Total RNAs were pre-
pared from various pre-B cell lines
and a B-cell leukemia (BCL1-B20), and
were analyzed by Northern blot using
32p-labeled probes: (A) C/z, (B))5, (C)
c-fms, or (D) -actin as probes.
(c) (d)
-18S
Probe c-fms Probe [-actin
vation compatible with the slower proliferation of
normal, or cultured, macrophages than early
B-lineage cells. They had nearly 2-3 times the mean
cell volume of their lymphoid counterparts, and
adhered to culture flasks to varying degrees.
To examine the effect of IL-5 on the conversion of
pre-B cells into macrophages by GM-CSF, we
cultured J13 cells on ST2 layers with GM-CSF in
combination with various amounts of IL-5 (0.5 to
50 U/ml). IL-5 inhibited conversion of pre-B cells by
GM-CSF into macrophages in a dose-dependent
manner. Limiting dilution analysis revealed that the
frequency of conversion of the pre-B cell line J13 by
GM-CSF into macrophages (J13GM) was approxi-
mately 1/500 and was less than 1/20,000 when IL-5
(50 U/ml) was added with GM-CSF. Attempts to
regenerate B-lineage cells from macrophages by IL-5
were unsuccessful.
DISCUSSION
We have shown here that nontransformed Ly-1
/
early B-lineage cell lines of the J .series can be
converted to Ly-1
/ macrophages under the influence
of 5-azacytidine or GM-CSF. The four cloned cell
lines that underwent this dramatic conversion
included two at the early B precursor stage (J10 and
J2) and two at the pre-B stage (J13 and J1).
IL-5 can support the growth of early B cells onMACROPHAGE DIFFERENTIATION FROM PRE-B CELLS 119
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FIGURE 6. Expression of /z-chain,
but not r- or ,-chain on the surface
of pre-B cell lines. Pre-B cell lines
were stained with FITC-coupled anti-
/z, FITC-coupled anti-, antibody, or
phycoerythrin (PE)-coupled anti-c
antibody. Cells stained were analyzed
by a flow cytometer.
ST2 in LTBC-W after depleting mature .B cells from marrow cells from 3-week-old mice in the absence
bone marrow cells by Dexter-type LTBC (Tominaga of IL-5. Most of early B-cell lines grown in LTBC-W,
et al., 1989). However, myeloid cells in addition to however, died when they reached certain cell
lymphoid cells also grow on ST2 in the system numbers, usually from hundreds to several
described before. As we reported (Tominaga et al., thousand in the absence of IL-5. As assessed by
1989) and describe in this study, Ly-1 + B-lineage limiting dilution analysis for the cell growth, only
cells consist of a distinct population in the non- about 0.1% of those cells continued to grow on the
adherent fraction of 5-week LTBC-W of bone ST2 layer in the presence of IL-5. We thus estab-
,lEt Mac-1 Ly-1
RELATIVE FLUORESCENCE INTENSITY
J13
FIGURE 7. Phenotype characteristics of
the macrophage-converted clone. Pre-B
J13GM cell line (J13) or its macrophage-
converted cell line (J13GM) by the treat-
ment with GM-CSF for 5 weeks was
stained by FITC-coupled anti-/z, FITC-
coupled anti-Ly-1, or anti-Mac-1 plus
anti-rat :. Cells stained were analyzed by
a flow cytometry.120 S. KATOH et al.
FIGURE 8. Morphological and cyto-
chemical analysis of th macrophage-
converted clone. Part (A) shows the
converted J13 cells stained with
nonspecific esterase, and (B) demon-
strates their relative ability to phago-
cytose latex beads. The magnifications
in (A) and (B) were 400 x and 1000 x,
respectively. (See Colour Elate V at
the back of this publication.)
lished IL-5-dependent Ly-1
/ B-lineage cells in the
presence of IL-5 and ST2 stromal cells. Early
B-lineage cell lines established in this study
responded to IL-3 as well and IL-7 to a lesser extent.
However, it did not respond to IL-1, IL-2, or IL-4.
The supernatant from ST2 cells did not replace ST2
cells, strongly suggesting that cell-to-cell contact
between early B-lineage or pre-B cells and ST2 was
necessary to maintain growth.
It has been reported that B-cell precursors that
develop in LTBC-W without exogenous IL-3 did not
seem to give rise to Ly-1
/ early B cells (Dasch and
Jones, 1986; Palacios and Leu, 1986; Palacios et al.,
1987). There are at least two possibilities to account
for the amazingly high incidence of Ly-1
/ B-lineage
cells in our culture system. First, it may be related
to the age of bone marrow donors used on starting
materials for LTBC-W, because-precursors of Ly-1
B cells exist in fetal liver, but are rare in adult bone
marrow (Hayakawa et al., 1985). Second, it may
have been caused by IL-5 itself. As shown in Figure
1A, Ly-1
/ cells were preferentially detectable when
we cultured bone marrow cells from 3-week-old, but
not from 8-week-old DBA/2J mouse. Ly-1
/ B lineage
cells were also enriched in the period of culture only
in the presence of IL-5 (Fig. 1B). We postulate that
there may be precursor cells in bone marrow of Ly-
1
/ B-lineage cells. When IL-5-independent and ST2-
dependent pre-B-lineage cells (MJ88-1: sIgM-,
cIgM /, Mac-l-, Ia-, Thy-l-, IL-2R(Tac)-, CD45R /,
and IL-5R-) were cultured with IL-5 on the ST2
layer, expression of Ly-1 antigens remained negative
(unpublished observations), suggesting that IL-5
does not induce expression of Ly-1 antigen on Ly-1-
early B-lineage cells.
Ly-1
/ pre-B cell lines analyzed in this study
expressed mRNA for membrane-type /-chain and
,5 (Fig. 5). MJ88-1 also expressed ;5 mRNA. In
contrast, the T-88 cell line that grows in an IL-5-
dependent and ST2-independent manner did not
express 5 mRNA (unpublished observation),
suggesting that ,5 mRNA expression might correlate
to stromal-cell dependency rather than IL-5 depend-
ency. A striking feature of cell lines of the J series is
that they express higher levels of c-fms mRNA
compared with the MJ88-1 line (Fig. 5). The c-fms
expression was also observed at the pro-B stage in
the J series lines (data not shown), suggesting an
earlier commitment of these Ly-l+-lineage cells to be
able to differentiate into macrophages.
Our data demonstrate unequivocally that normal
Ly-1
/ B-lineage cell lines can be converted into
macrophages by the treatment with 5-azacytidine or
GM-CSF (Figs. 2, 3, 5, 7, and 8). The myeloid
derivatives were adherent and phagocytic and had
the morphology and size of macrophages (Figs. 3
and 8). They were independent of 2-ME, and dis-
played myeloid surface markers Mac-1 (Figs. 2 and
7), Mac-2, and F4/80 (Austyn and Gordon, 1981).
Indeed, in every respect tested, they were indis-
tinguishable from mature macrophages. Ly-1-pre-B
cell lines did not convert to macrophages in someMACROPHAGE DIFFERENTIATION FROM PRE-B CELLS 121
circumstances, including the addition of GM-CSF or either lymphomas or preleukemia bone marrow cells
5-azacytidine (data not shown), suggesting that of E-myc transgenic mice, were infected with a
B-lineage cells maintained on ST2 in the presence of retrovirus bearing v-raf (Klinken et al., 1988). The
IL-5 may have distinct potential from those main- B-cell/macrophage switch might occur either by
tained in the absence of IL-5. It was reported that regression to a putative common lymphoid/myeloid
exposure of the pre-B lymphoma ABLS 8.1 to precursor or by direct adoption of the macroplaage
5-azacytidine induced derivation of macrophagelike differentiation program. Although most of our
lines (Boyd and Schrader, 1982), and 5-azacytidine results are compatible with either explanation, it is
induced differentiation of IL-3-dependent cells into noteworthy that cells of other hemopoietic lineages
mature B cells (Palacios et al., 1987; Kinashi et al., have not been observed in these experiments. Since
1988). Taken all together, DNA demethylation and granulocytes and macrophage diverge in myeloid
gene activation of early B-lineage cells by 5-azacyti- differentiation (Kincade, 1987), the absence of cells
dine may be one mechanism to control conversion of granulocyte morphology tends to favour direct
to macrophage differentiation (Jones, 1985). switching to the mature of immature macrophage
Thus, cells well along the Ly-1
/ B-lineage differ- phenotype.
entiation pathway acquired many features associated In summary, cell lines characteristic of nontrans-
with the last stages of myeloid differentiation. It formed B-Iineage ceils are obtained from cells co-
might be argued that GM-CSF did not induce these cultivated with a stromal-cell layer and IL-5. In
dramatic changes, but instead rescued rare spon- addition, four cell lines were found to co-express
taneous transforman:s. This seems to be unlikely in antigens usually restricted to the B-cell or myeloid
the case of GM-CSF, because GM-CSF induced the pathways of differentiation. Detailed analysis sug-
differentiation of Ly-1
/ B-lineage cells to macro- gest that the initial cells giving rise to these lines
phages only with the reduced rate of growth, derived from a precursor common to the B-cell and
Another possibility is the involvement of autocrine myeloid lineages. IL-5 may only be required for sup-
factor production, which may occur normally at porting survival of the Ly-1
/ B-cell/macrophage
some stage of myeloid differentiation. We cannot progenitors, and M-CSF and/or GM-CSF appears to
rule out this possibility at this time. The fact that be required for conversion rather than growth sup-
IL-5 shows no significant effect on 5-azacytidine- port of spontaneously generated macrophages.
induced conversion of Ly-1
/ early B-cell precursors
to macrophages appears to be contradictory to the
observation that IL-5 inhibits the conversion of Ly-
1
/ pre-B cells to macrophages in response to GM- MATERIALS AND METHODS CSF. IL-5 might inhibit the signal transduction of
GM-CSF. The effect of 5-azacytidine on B-lineage Mice cells may be irrelevant with that of IL-5, because
this drug affects the DNA directly. DBA/2J mice were purchased from CLEA Japan Inc.
Although we provide here the first evidence that (Tokyo). C3H/HeN IL-5 transgenic mice were
treatment of nontransformed early B precursor cells produced (Tominaga et al., 1990) and were main-
with 5-azacytidine or GM-CSF, and nontransformed tained in the animal facility of our university.
pre-B cells with GM-CSF provoke this switch, other
lymphoid cell lines that could produce macrophages
have been described-previously (Boyd and Schrader, Cytokines
1982; Bauer et al., 1986; Holmes et al., 1986; Recombinant mouse IL-5 [rIL-5, 2.2x10 units (U)/g
Seremetis et al., 1987; Davidson et al., 1988; protein] was purified from cultured supernatant of
Klinken et al., 1988). HAFTL-3, v-ras transformed IL-5 cDNA-transfected Chinese hamster ovary
pre-B lines, spontaneously generated subpopulations (CHO) cells according to the procedures previously
of Mac-1 expressing cells (Davidson et al., 1988), described (Harada et al., 1987). Human rIL-1
and the macrophage line P388D1 shares immuno- (2.0x10 U/g)and human rIL-2 (4.3 xl0TM U/g)were
globulin rearrangements with the lymphoblastic line. kind gifts by Dr. Y. Hirai (Tokushima Research
P388 derived from the same tumor (Bauer et al., Institute, Ohtsuka Pharmaceutical Co., Japan) and
1986). Furthermore, switching to the myeloid lineage Dr. A. Kakinuma (Central Research Division, Takeda
occurred frequently when B-lineage cells, from Chemical Industries Ltd., Osaka, Japan), respec-122 S. KATOH et al.
tively). Murine rIL-3 (1.0 xl011 U/g) and murine IL-4
(1.0 xl01 U/g) were kindly provided by Dr. K. Arai
(DNAX Research Institute, Palo Alto, CA) and Dr.
K. Hama (Ono Central Research Laboratory, Osaka,
Japan), respectively. Murine rIL-7 (4.0xl02U/g)
(Sudo et al., 1989), murine rGM-CSF, and murine
rIL-6 were generous gifts from Dr. T. Sudo (Bio-
material Research Center, Kamakura). We used ten-
times concentrated supernatants as a M-CSF source
of L cells (Kincade et al., 1979).
Reagent and Antibodies
The following monoclonal antibodies were used for
the surface staining: fluorescein isotliocyanate
(FITC)-conjugated anti-Ly-1 (clone 53-7.3) and anti-
Thy-1, and phycoerythrin (PE)-conjugated anti-
mouse c antibodies (Becton-Dickinson, Mountain
View, CA); FITC-conjugated anti-I-Ad (Meiji Insti-
tute of Health Science, Tokyo); FITC-conjugated
anti-IgM antibody (LO-MM-9) (Serotec Ltd., Black-
thorn, Bicester, England); FITC-labeled anti-IgL
(lambda, 1 +2) (PharMigen, San Diego, CA); anti-
Mac-2 (Boehringer Mannhein, West Germany); and
FITC-labeled anti-rat c-chain (MAR18.5) mAb, anti-
IL-2R (7D4) mAb, and goat anti-mouse /-chain
antibodies. (prepared according to the procedures
previously described (Riggs et al., 1958); and super-
natants containing anti-Mac-1 M1/70 (Springer et
al., 1979), anti-CD45R (RA3-6B2) (Coffman and
Weissman, 1981), and anti-Lyb-2.1 (clone 9-6.1)
(Southern, 1975) (kindly provided by Dr. H. Yakura,
Tokyo Metropolitan Institute for Neuroscience,
Tokyo, Yakura et al., 1981). 5-azacytidine was pur-
chased from Sigma Fine Chemicals (St. Louis, MO).
Culture and Cell Lines
RPMI 1640 medium and FCS were from Sigma and
Microbiological Associates (Walkersville, MD),
respectively. The complete medium described by
Whitlock and Witte was used throughout this study
that is, RPMI 1640 supplemented with 5% FCS,
50/M 2-ME, 50 g/ml streptomycin, and 50 U/ml
penicillin. ST2 stromal-cell line (Ogawa et al., 1988)
was kindly provided by Dr. S.-I. Nishikawa
(Kumamoto University Medical School). IL-5- and
ST2-dependent cell lines have been established
according to procedures as previously described
(Tominaga et al., 1989). In brief, we started from the
original LTBC-W of 3-week-old mice. After 5 weeks,
2 xl0 nonadherent cells were transferred onto the
ST2 layer and cultured in the presence of rIL-5
(50 U/ml). Two weeks later, 30 colonies were found
in a well, and cells from each colony were trans-
ferred into a 25-cm tissue-culture flask (SH-
FLO25SW; TERUMO, Tokyo) with fresh ST2 layer
and maintained for 3 months in the presence of IL-
5. Eventually, we established 18 clones that were
further analyzed in these studies. Cells .growing on
ST2 were fed with the medium for LTBC-W con-
taining IL-5 (50 U/ml) twice a week. Cloning of cell
lines was carried out by a limiting dilution technique
using a flat-bottomed 96-well plate (Corning) with a
ST2 cell layer in the presence of IL-5. A MJ88-1 cell
line was established at the same time by the same
procedures except that cells were cultured in the
absence of IL-5. Growth of MJ88-1 is ST2-dependent
and IL-5-independent.
Induction of Differentiation
Induction of differentiation of B cells by using
5-azacytidine was carried out according to methods
originally described by Boyd and Schrader (1982)
with slight modifications. In brief, early B-cell clones
[Sx106/ml in 4ml of IL-5 (50U/ml)-containing
medium] were exposed in a 25-cm flask (TERUMO,
Tokyo) to several concentrations of freshly prepared
5-azacytidine (from 2 to 20/zg/ml) at 37C for 24 h.
After this step, 4ml of IL-5-containing medium
without 5-,azacytidine was added to the culture and
incubated at 37C. After 3 days, the cells were har-
vested, washed twice in the medium, and the viable
cells (approximately 10% of the starting population)
were co-cultured on the ST2 layer at 2-3 xl05 cells/
ml with medium containing IL-5. The culture
medium Was changed into fresh IL-5 containing
medium twice a week. Nonadherent cells were har-
vested and monitored for the presence of/z +, Ly-l+,
CD45R +, and Mac-1 + cells for 5 weeks after expo-
sures to the drug.
Pre-B cells "(2 xl06) were co-cultured with ST2 in
25-cm flasks in a final volume of 7-ml culture
medium in the presence of various cytokines: GM-
CSF (100U/ml), M-CSF (10% of LCCM), IL-4
(100 U/ml), IL-5 (50 U/ml), or IL-7 (100 U/ml). The
cultures were monitored for the presence of Mac-1
/
or sIgM + cells 14, 21, and 40 days after exposure to
cytokines.
Limiting Dilution Analysis
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described in Methods (Ogawa et al., 1988). Cells (10
to 10,000 per well with a threefold dilution) were co-
cultured with IL-5 (50 U/ml) and GM-CSF (100 U/
ml), or in the presence of GM-CSF alone on the ST2
layer for 4 weeks.
Immunofluorescence Staining and Flow Cytometry
Analysis
Expression of cell-surface antigen was analyzed by
flow cytometry as previously described (Tominaga et
al., 1989). Cells (1 X106) were stained directly with
50/zl of FITC- or PE-conjugated antibody (20/zg/ml)
for 20 min on ice and washed three times with 5%
FCS-PBS. In some cases, 1 X10 cells were incubated
with 50/1 of antibodies (20/zg/ml) for 20 min on
ice. After washing once, the cells were then stained
with 50/zl of FITC-conjugated anti-rat c-light chain
antibody (MAR18.5) (20/g/ml). For analysis, EPICS
V (Coulter Co., Hialeah, FL) was used and only the
cells within the lymphocyte gate were counted as
described (Tominaga et al., 1989).
Morphological Determination of Cultured Cells
Cytocentrifuge preparations of cells were stained
with May-Grunwald and Giemsa solution (Merck,.
Darmstadt, FRG). All the cells that had polymorphic
nucleus were counted as polymorphonuclear (PMN)
cells. The rest of the cells were further classified into
mononuclear cells of small, medium, and large size.
In this classification, particularly for the cells in
LTBC-W, all small mononuclear cells are actually
small lymphocytes, but large- and medium-size
mononuclear cells may include immature cells of
other hemopoietic cell lineages as well as lymphoid
cell lineage.
Assays for Macrophage Characteristics
Nonspecific esterase granules were detected by the
c-naphtylbutyrate (Sigma) method (Li et al., 1973).
Phagocytic activity was determined at 37C by
adding 1/m latex beads (Sigma) to the cultures and
by examining the cultures 3 h later; cells were col-
lected, cytocentrifuged, and stained with
May-Grunwald-Giemsa, and the percentage of
nonspecific esterase-positive cells that had taken up
beads was scored at 400 x magnification.
Southern Blot Analysis
Preparation of high molecular weight DNA,
Southern blot analysis, and hybridization with the JH
probe were carried out according to the methods
previously described (Southern, 1975; Tominaga et
al., 1989). In brief, 5/g of DNA from cloned cell
lines and DBA/2J liver cells were digested to com-
pletion with EcoRI or BamHI (Toyobo Co. Ltd.,
Osaka, Japan), then separated on 0.8% agarose gels
and transferred to nylon .membrane filters (Gene
Screen Plus, NEN-Du Pont, NJ) for hybridization.
Southern blots were hybridized with 32p-labeled
DNA probes at 42C in a buffer containing 50%
formamid, 1% SDS, 1M NaC1, 10% dextran
sulfate, and 250/g/ml salmon sperm DNA. The 32p_
labeled probes were labeled using a Oligolabeling
Kit (Pharmacia Fine Chemicals, Uppsala, Sweden).
Bands that hybridized with labeled probes were
detected by autoradiography with RXO-H film (Fuji
Photo Film Co. Ltd., Tokyo, Japan) and Du Pont
intensifying screen. The probes used were a JH4
probe, 2.6 kb HindIII-BamHI fragment (Sakano et al.,
1981) containing JH4 gene (a generou’s gift of Dr. T.
Honjo, Kyoto University); J, a 1.6 kb HindIIi-XbaI
fragment (Sakano et al., 1979) of Bluescript-KS
containing Jl-J5 gene (a kind gift from Dr. Y.
Kurosawa, Fujita Medical College).
RNA Analysis
RNA was prepared according to the described
methods using the acid guanidinium thiocyanate-
phenol-chloroform method (Chomczynski ,and
Sacchi, 1987). The methods used for Northern
blotting are essentially the same as those described
by Lehrach et al. (1977). Twenty micrograms of
RNA were electrophoresed through 1.5% agarose
horizontal gels in I x MOPS buffer (0.2M morpho-
linopropanesulfonic acid s(dium salt, 0.05 M sodium
acetate, 0.01 M Na2EDTA (pH is adjusted to 7.0 with
acetic acid) (pH 7.0), and 6% formamide at 20 to
30 V for 16 h, and directly transferred to Gene
Screen membrane (NEN-Du Pont, NJ). The blot was
baked in a vacuum oven for 3 h at 80C. The RNA
blot was prehybridized for 8 to 20 h at 42C in the
p’ehybridization buffer, which contains 50% (vol/
vol) formamide, 50mM Tris-HC1 (pH 7.5), 1M
NaC1, 0.1% sodium pyrophosphate, 1% SDS,
denatured salmon sperm DNA at 250/g/ml, .10%
dextran sulfate, and 0.2% each of bovine serum
albumin, Ficoll, and polyvinylpyrrolidone. After
incubation of the RNA blots of 42C with 5 X10
CPM of 32p-labeled DNA fragments in the same
buffer, the filters were rinsed with two changes of
0.5 xSSC for 5 min each at room temperature and124 S. KATOH et al.
then washed with two changes of 0.5 xSSC-1% SDS
for 15 min each at 65C followed by two changes of
0.1 xSSC at room temperature. Kodak XAR-5 X-ray
film was exposed to the filters for 1 to 3 days at
-80C, using intensifying screens to obtain auto-
radiographs. The 32p-labeled DNA probes used were
the following: C/ probe, the 1.6-kb Hae II fragment
from /-heavy-chain constant region-specific cDNA
plasmid (pAB/-I) (Alt et al., 1980) that includes
most CH3 and entire CH4 domains, kindly provided
by Dr. Alfred Bothwell (Yale University, New
Haven, CN); 5 probe, a 0.26 kb EcoRI fragment of
pZ183-1a (Sakaguchi and Melchers, 1986; Kudo et
al., 1987); and v-fms, a1.4 kb Pstl fragment of feline
sarcoma virus (Donner et al., 1982) (from American
Tissue Culture Collection, Rockville, MD); and
actin, 0.33 kb EcoRI fragment of pMA/J-3’ untrans-
lated region (Tokunaga et al., 1986) (kindly provided
by Dr. K. Tokunaga, Chiba Cancer Research Insti-
tute, Chiba, Japan).
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